A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2006
11/02/2006	US20060247244 Quinoxalinones and their use especially in the treatment of cardiovascular diseases
11/02/2006	US20060247243 Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors
11/02/2006	US20060247241 2,4-Di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
11/02/2006	US20060247240 Method of treatment and/or prevention of brain, spinal or nerve injury
11/02/2006	US20060247239 Melanin concentrating hormone antagonists
11/02/2006	US20060247238 5-Chloro-thiophene-2-carboxylic acid ((3S ,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide; anticoagulant, inhibit coagulation factor Xa
11/02/2006	US20060247237 Macrocyclic quinazoline derivatives as antiproliferative agents
11/02/2006	US20060247236 micronized 5-(4,4-dimethyl-2-oxo-1,4-dihydro-2H-3,1-benzoxazin-6-yl)-1H-pyrrole-2-carbonitrile; progesterone receptor modulator; contraception, hormone replacement therapy, carcinomas, dysfunctional bleeding, uterine leiomyomata, endometriosis, polycystic ovary syndrome; storage stable
11/02/2006	US20060247235 progesterone receptor modulator and is effective in contraception, hormone replacement therapy, and treating carcinomas and adenocarcinomas, dysfunctional bleeding, uterine leiomyomata, endometriosis, and polycystic ovary syndrome
11/02/2006	US20060247234 Compositions containing micronized tanaproget prepared by wet granulation
11/02/2006	US20060247233 Thiazoles inhibitors of the alk-5 receptor
11/02/2006	US20060247232 Heterocyclic compound and antitumor agent containing the same as effective ingredient
11/02/2006	US20060247231 Amide and ester matrix metalloproteinase inhibitors
11/02/2006	US20060247230 chemokines receptor modulators such as 4-(2-ethyl-6-fluoro-3-{1-[3-(4-fluoro-phenylsulfanyl)-propyl]-piperidin-4-yl}-indol-1-yl)-benzoic acid ethyl ester, used for treating inflammatory diseases such as asthma and allergic diseases, autoimmune pathologies such as rheumatoid arthritis and atherosclerosis
11/02/2006	US20060247229 Sulfonyl substituted n-(biarylmethyl) aminocyclopropanecarboxamides
11/02/2006	US20060247228 Phenylazole compounds production process and antioxidants
11/02/2006	US20060247227 Substituted piperidines as histamine h3 receptor ligands
11/02/2006	US20060247226 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
11/02/2006	US20060247225 e.g. (1 alpha ,5 alpha ,6 alpha )-N-[3-(4-methyl-3-pentenyl)-3-azabicyclo[3.1.0]hex-6-yl]-2-hydroxy-2-cyclopentyl-2-(4-methoxy)phenylacetamide; respiratory, urinary and gastrointestinal systems disorder; antidiabetic agent
11/02/2006	US20060247224 Melanocortin receptor ligands
11/02/2006	US20060247223 Non-imidazole alkylamines as histamine H3- receptor ligands and their therapeutic applications
11/02/2006	US20060247222 Glycosidase inhibitors and methods of synthesizing same
11/02/2006	US20060247221 Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy
11/02/2006	US20060247220 Preventing the crystallization of cholesterol using oxysterols
11/02/2006	US20060247219 Specific glucocorticosteriod compound having anti-inflamatory activity
11/02/2006	US20060247218 Treatment of congestion using steroids and adrenergics
11/02/2006	US20060247217 Tricyclic protein kinase inhibitors
11/02/2006	US20060247216 Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
11/02/2006	US20060247215 (Z)-7-{(1R,2R)-2-[(E)-5-(3-Chloro-benzo[b]thiophen-2-yl)-3-hydroxy-pent-1-enyl]-6-oxo-cyclohexyl}-hept-5-enoic acid; ocular hypotensives; glaucoma
11/02/2006	US20060247214 Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
11/02/2006	US20060247213 Plasma carboxypeptidase b inhibitors
11/02/2006	US20060247212 Heterocyclic compounds having inhibitory activity against HIV integrase
11/02/2006	US20060247211 Cytotoxic indeno and isoindoloisoquinolones
11/02/2006	US20060247210 such as (4-Benzothiazol-2-yl-1H-pyrazol-3-yl)-[2-(1H-imidazol-4-yl)-ethyl]-amine, used in the treatment of disorders associated with hyperproliferation and tissue remodelling or repair, inflammation, cell migration and invasion, and renal diseases, or as protein kinase inhibitors
11/02/2006	US20060247209 such as N-chloro-2,2-dimethyltaurine; for controlling growth of bacteria, microbes, spores, fungi or viruses; shelf-life
11/02/2006	US20060247208 B-cyclodextrin derivatives and their use against anthrax lethal toxin
11/02/2006	US20060247207 Use of alpha-ketoglutaric acid for the treatment of malnutrition or high plasma glucose condition
11/02/2006	US20060247206 Minimally invasive clinical treatment method for closure of umbilical hernias
11/02/2006	US20060247205 anti-infective to combat infection associated with burns, surgery, chemotherapy, bone marrow disorders and other conditions in which the immune system may be compromised; high molecular weight determined by multi-angle laser light scattering (VHMW-glucan)
11/02/2006	US20060247204 New therapeutic use of chondroitin sulphate
11/02/2006	US20060247203 Freeze-dried preparation containing methylcobalamin and process for producing the same
11/02/2006	US20060247200 Methods and uses of leukotriene B4 hydroxylases to treat diseases
11/02/2006	US20060247199 Methods and products for manipulating uncoupling protein expression
11/02/2006	US20060247190 Compositions and methods for treating human papillomavirus mediated disease
11/02/2006	US20060247189 Forms of 5-Azacytidine
11/02/2006	US20060247188 Effective treatment of tumors and cancer with triciribine and related compounds
11/02/2006	US20060247187 Attenuation of disorders by aminoglycosides
11/02/2006	US20060247186 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
11/02/2006	US20060247185 Stabilization of amrubicin hydrochloride
11/02/2006	US20060247184 Treatment and prophylaxis of diseases and infections pigs and poultry
11/02/2006	US20060247183 Compositions and methods for the treatment of inflammatory conditions of mucosae, skin and the eye
11/02/2006	US20060247182 Witherferin A derivatives and analogs extracted from Withania somnifera; preferential COX-2 inhibitors with little or no COX-1 activity; anticarcinogenic agents
11/02/2006	US20060247181 Tigecycline compositons and methods of preparation
11/02/2006	US20060247180 Purgative composition and uses thereof
11/02/2006	US20060247179 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
11/02/2006	US20060247178 Mitotic kinesin inhibitors and methods of use thereof
11/02/2006	US20060247174 Use of a peptide
11/02/2006	US20060247171 Use of a peptide
11/02/2006	US20060247167 Stable formulations of peptides
11/02/2006	US20060247161 Use of active ingredients for the prophylaxis and/or therapy of viral diseases
11/02/2006	US20060247160 Administering a polypeptide or biologically active fragment; reducing body mass; metabolic-related diseases, hyperlipidemias, atherosclerosis, diabetes, and hypertension
11/02/2006	US20060247155 Methods for alleviating deleterious effects of 3-deoxyglucosone
11/02/2006	US20060247152 Substituted fullerenes and their use as inhibitors of cell death
11/02/2006	US20060246587 Methods for transfecting T cells
11/02/2006	US20060246586 Chromosome-based platforms
11/02/2006	US20060246486 Human signal peptide-containing proteins
11/02/2006	US20060246164 Medicament containing Epimedium extract for treatment of prostatic hyperplasia and prostatitis
11/02/2006	US20060246162 Antiestrogenic glyceollins suppress human breast and ovarian carcinoma proliferation and tumorigenesis
11/02/2006	US20060246161 Method of making medicament for treating anemia
11/02/2006	US20060246160 Cyclooxygenase-2 inhibitory withanolide compositions and method
11/02/2006	US20060246159 A mixture of withanolides from leaves of Withania somnifera A; preferential COX-2 inhibitors with little or no COX-1 activity; anticarcinogenic agents
11/02/2006	US20060246158 (2,2-dimethylcyclo-propanone)-4-oxy-5,6-epoxy-2,3-dihydrowithaferin A; preferential COX-2 inhibitors with little or no COX-1 activity; anticarcinogenic agents
11/02/2006	US20060246156 Crude extracts from andrographis paniculata
11/02/2006	US20060246155 Method of treating impaired mitochondrial function
11/02/2006	US20060246153 Herbal compositions for the teatment and prevention of prostate disorders
11/02/2006	US20060246148 Anti-bacterial, anti-virus, and anti-fungus composition, its preparation and use
11/02/2006	US20060246144 Microcapsules containing biocide and preparation thereof by solvent evaporation technique
11/02/2006	US20060246142 Nanoparticulate quinazoline derivative formulations
11/02/2006	US20060246141 Nanoparticulate lipase inhibitor formulations
11/02/2006	US20060246140 Method for the preparation of molecular complexes
11/02/2006	US20060246138 Polyoxaester suspending vehicles for use with implantable delivery systems
11/02/2006	US20060246137 Complex matrix for biomedical use
11/02/2006	US20060246133 Controlled release pharmaceutical compositions of liothyronine and methods of making and using the same
11/02/2006	US20060246132 Sustained release formulations of venlafaxine
11/02/2006	US20060246131 Use of metformin to counteract weight gain associated with psychotropic medications
11/02/2006	US20060246130 Compositions and methods for combination antiviral therapy
11/02/2006	US20060246129 Composition for use in treatment of sleep problems and method for same
11/02/2006	US20060246124 Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally
11/02/2006	US20060246122 Solid transdermal therapeutic system with UV absorber
11/02/2006	US20060246117 Animal husbandry method for administering a vitamin E derivative and formulation
11/02/2006	US20060246115 Nutritional products for ameliorating symptoms of rheumatoid arthritis
11/02/2006	US20060246114 Multiple component food product useful for delivering glucosamine and/or nacetyl-d-glucosamine
11/02/2006	US20060246111 Polysaccharides as ultrasound transmission media
11/02/2006	US20060246110 Sustained release pharmaceutical composition
11/02/2006	US20060246106 Infection resistant medical implants
11/02/2006	US20060246101 Oral controlled release formulations
11/02/2006	US20060246100 Method for exfoliating skin
11/02/2006	US20060246099 Compositions containing piperazine compounds
11/02/2006	US20060246098 Stable aqueous-based emulsion formulation comprising urea and salicylic acid and method of using same
11/02/2006	US20060246085 Methods for manipulating satiety

1 ... 4025 4026 4027 4028 4029 4030 4031 4032 4033 4034 4035 4036 4037 4038 4039 4040 4041 4042 4043 4044 4045 ... 7860